Relmada Therapeutics, Inc.

$RLMD, which focuses on the research and development of transformative medicines for those living with central nervous system (CNS) disorders, currently has its lead candidate REL-107 in Phase 3 trials.

Share This Article

 

About the Author

Relmada Therapeutics, Inc.

Joey Ramson